JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB65336

Triglyceride Assay Kit - Quantification

4

(4 Reviews)

|

(593 Publications)

Triglyceride Assay Kit ab65336 is a quantitative, addition-only assay with a 20 min and a 60 min incubation step. In the assay, triglycerides are converted to free fatty acids and glycerol, and the glycerol is then oxidized. Readout is on any colorimetric (570 nm) or fluorometric (Ex/Em 535/587 nm) plate reader.

- BIOVISION® assay kit
- Cited in over 500 publications
- Complete kit including standard curve for quantitation
- Used with sample types including tissue extracts, cell lysates, serum, heparin plasma, urine (UTI) and other biological fluids
- Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
12 Images
Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)
  • Biochemical assay

Lab

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

Diagram showing the principles of the Triglyceride assay method.

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)
  • Biochemical assay

PubMed

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

Triglyceride assay kit ab65336 and free fatty acid assay kit ab65341 used with heart tissue.

Han et al. used Triglyceride assay kit ab65336 and Free Fatty Acid assay kit ab65341 to investigate cardiac abnormalities in high fat diet fed mice when researching the role of the long non-coding RNA Lipid-Droplet Transporter (LIPTER).

The concentration of free fatty acids (FA) (f, n = 5 mice each group) were quantified using the Free Fatty Acid Assay kit (ab65341), and triglyceride (TG) concentrations (g, n = 7 mice each group) were quantified using the Triglyceride Quantification Assay Kit (ab65336).

Approximately 25 mg of mouse heart tissue per heart was collected and homogenized in 500 μl lipid extraction buffer (ab211044) using a Beadbug Homogenizer. After centrifugation, the supernatant was removed to a new tube. FA or TAG concentration was measured according to the manufacturer’s protocols. The FA and TAG concentrations in WT and genetically modified mouse hearts were normalized to the collected heart tissue weights.

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)
  • FuncS

PubMed

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)

Hepatic triglyceride levels was measured using ab65336 in male and female wild-type (WT) or AT2KO (knockout) mice with either normal diet (ND) or high fat diet (HFD).

Image from Samuel P et al., PLoS One 8(1), Fig 7b. doi: 10.1371/journal.pone.0048425. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)
  • FuncS

Lab

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)

Fluorometric triglyceride standard curve : mean of duplicates (+/- SD) with background reads subtracted

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)
  • FuncS

Supplier Data

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)

Colorimetric triglyceride standard curve using ab65336.

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)
  • FuncS

Lab

Functional Studies - Triglyceride Assay Kit - Quantification (AB65336)

Triglyceride measured in cell culture lysates showing quantity (nmol) per 1 mln cells.

Samples with the concentration of 1e7 cells/mL were used. Samples were diluted 40-80 fold and measured fluorometrically.

HepG2 cells were treated with 25 uM Chloroquine for 72h.

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)
  • Biochemical assay

PubMed

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

Triglyceride assay kit ab65336 and cholesterol assay kit ab65359 used with HepG2 cell lysates.

Pozzi et al. used used the triglyceride assay kit and cholesterol assay kit to investigate the effect of antipsychotics on the SREBP pathway and on AMPK activation.

HepG2 cells serum-starved overnight and pre-treated with DMEM low glucose 20% FBS for 3 h, were incubated with 5 μM U18666A, 25 μM risperidone (RIS), ziprasidone (ZIP) or olanzapine (OLA), the SREBP2 positive control lovastatin 25 μM (LOV), and the SREBP1 positive control T0901317 10 μM (T09) for 24 h.

Triglycerides (TG) were extracted and quantified from HepG2 cells treated with the indicated compounds using Abcam ab65336. Briefly, 5 x 10^6 cells were harvested and lysed in 5% v/v NP-40, then samples were repeatedly heated at 98°C to solubilise triglycerides; a sample was taken for BCA protein quantification as normaliser, and the indicated amount of sample was processed with lipase and reaction reagents. Fluorescence emitted by the chromogen dye was quantified on Fluoroskan microplate reader (Ascent FL, Thermo Fisher Scientific) at 544/590 nm. Triglyceride fluorescence was reported as fold increase over levels of untreated cells (one way ANOVA followed by Dunnett's multiple comparison test, n > 3 experiments; *vs. unt cells).

Total cholesterol was extracted from HepG2 cells treated with the indicated compounds by using cholesterol assay kit ab65359. Briefly, 10^6 cells were harvested and lysed in 100 mM NaCl, 10 mM TRIS pH 7.4, 1 mM EGTA, 2 mM MgCl2 and 1% v/v Triton-X100; samples were repeatedly vortexed and chilled on ice to solubilise cholesterol; a sample was taken for BCA protein quantification as normaliser, while the rest was mixed with isopropanol-chloroform 11 : 7 and centrifuged to separate the organic phase containing cholesterol. The organic phase was taken and evaporated, cholesterol was then resuspended and processed with cholesterol esterase and reaction reagents. Fluorescence emitted by the chromogen dye was quantified on Fluoroskan microplate reader at 544/590 nm. Cholesterol fluorescence was reported as fold increase over levels of untreated cells (one way ANOVA followed by Dunnett's multiple comparison test, n > 3 experiments; *vs. unt cells).

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)
  • Biochemical assay

PubMed

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

Triglyceride assay kit ab65336 and free fatty acid assay kit ab65341 used with liver tissue and plasma samples respectively.

Samuel et al. used the triglyceride assay kit and free fatty acid assay kit to understand gender differences in metabolic syndrome disorders in angiotensin receptor AT2R knockout mice.

Plasma free fatty acid levels were measured by colorimetric method using the Abcam free fatty acid quantification kit.

Hepatic triglyceride levels was measured using ab65336 in male and female wild-type (WT) or AT2KO (knockout) mice with either normal diet (ND) or high fat diet (HFD). For hepatic triglyceride measurement, livers were dissected and snap-frozen in liquid nitrogen and stored at −80°C. In brief, lipids were extracted by homogenizing 25 mg liver tissue in 1 ml 5% Triton-X100 in water, then slowly heated to 80°C in water bath for 5 min. The samples were cooled down and again heated to solubilize all triglycerides into solution. The samples were centrifuged for 5 min and supernatants were diluted 10 fold with dH2O for quantification.

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)
  • Biochemical assay

PubMed

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

Triglyceride assay kit ab65336 and cholesterol assay kit ab65390 used with mouse serum.

Zuo et al. used Triglyceride assay kit ab65336 and Cholesterol assay kit ab65390 to investigate the impact of hepatocyte-specific AAV-mediated knockout of ANGPTL3 in mice.

Measurements of serum triglyceride (TG) and total cholesterol (TC) in mice at 1–4 weeks after AAV9-hAAT-Anc/Angptl3 administration. The control (Ctrl) mice received no treatments.

Blood samples collected from the animals were allowed for clotting at room temperature for 10 min. Serum was isolated by centrifugation at 5000 rpm for 10 min and stored at -80 °C in small aliquots. Determination of TG and TC was performed using the triglyceride and cholesterol assay kit (Abcam, ab65336 and ab65390, respectively) according to the manufacture’s instruction.

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)
  • Biochemical assay

PubMed

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

Triglyceride assay kit ab65336 and Free Fatty Acid assay kit ab65341 used with mouse liver tissue.

Yue et al. used triglyceride assay kit ab65336 and free fatty acid assay kit ab65341 to investigate the protective effects of IL-22 on alleviating alcoholic hepatitis.

Administration of IL-22 reduces alcohol-induced lipid accumulation in mouse liver. PF (pair fed), AF (alcohol fed), AF+IL-22 (alcohol fed with IL-22 treatment).

(A) BODIPY 493/503 staining of mouse liver. Neutral lipids were stained in green, and nuclei were counterstained in blue. (B) Hepatic triglyceride (TG) and free fatty acid (FFA) levels.

Quantification assays of triglycerides (TG) and free fatty acids (FFA) in the liver were conducted using commercial kits from Abcam (Waltham, MA; ab65336 and ab65341) per the manufacturer’s instructions.

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)
  • Biochemical assay

PubMed

Biochemical assay - Triglyceride Assay Kit - Quantification (AB65336)

Triglyceride assay kit ab65336, Cholesterol assay kit ab65390, and Free Fatty Acid assay kit ab65341 used with rat serum and rat liver.

Li et al. used Triglyceride assay kit ab65336, Cholesterol assay kit ab65359, and Free Fatty Acid assay kit ab65341 to investigate the impact of using L. reuteri treatment to ameliorate the impact of biorhythm disorder-ignited dyslipidemia in long-term darkness treated rats.

The concentrations of triglycerides (TG), total cholesterol (CHOL), HDL-cholesterol (HDL-C), and free fatty acids (NEFA) in rat sera and liver tissues were detected using Triglyceride Quantification Assay Kit (ab65336), HDL and LDL/VLDL Cholesterol Assay Kit (ab65390). and Free Fatty Acid Quantification Assay Kit (ab65341), respectively. All procedures were carried out following the recommended instructions provided by the kit manufacturers.

Other - Triglyceride Assay Kit - Quantification (AB65336)
  • Other

Supplier Data

Other - Triglyceride Assay Kit - Quantification (AB65336)

Representative image of Triglyceride Assay Kit - Quantification ab65336

Components shown from left to right :

- OxiRed Probe

- Cholesterol Esterase

- Triglyceride Standard

- Enzyme Mix VI

- Assay Buffer 5

Note : The vial labels shown in this image use generic names for illustrative purposes only and may not exactly match the specific component names included in the kit.

Note : Colors of solutions in image may not precisely match the shade of colors in the actual kit.

Key facts

Detection method

Colorimetric/Fluorometric

Sample types

Heparin Plasma, Tissue Extracts, Serum, Other biological fluids, Cell Lysate, Urine (UTI)

Results type

Quantitative

Sensitivity

> 2 µM

Assay time

1h 20m

Assay Platform

Microplate reader

Product details

Triglyceride Assay Kit (ab65336) is a sensitive, easy assay to measure triglyceride concentration in mammalian samples.

Other names used to refer to this type of assay include TAG assay, TG assay, and triacylglycerol assay.

How the Triglyceride assay works
In the triglyceride assay protocol, triglycerides are converted to free fatty acids and glycerol by a lipase enzyme. Glycerol is then phosphorylated by glycerol kinase, and subsequently oxidized by glycerol phosphate oxidase to produce hydrogen peroxide. The hydrogen peroxide reacts with a probe via a peroxidase to generate color (spectrophotometry at λ= 570 nm) and fluorescence (Ex/Em = 535/587 nm).

Triglyceride assay protocol summary

  • - Add samples and standards to wells.
  • - Add assay buffer and lipase, and incubate for 20 min.
  • - Add triglyceride reaction mix and incubate for 60 min.
  • - Analyze with microplate reader.

Getting the best performance from ab65336
Please note: the general range is 0-10 nmol (colorimetric) and 0-1 nmol (fluorometric).

If your sample contains reducing substances, they are likely to interfere with the assay. In this case, we recommend using Triglyceride Assay Kit (Fluorometric, Reducing samples) ab178780.

Technical Note: Triglyceride is unlikely to be detectable in healthy urine but may be elevated in the presence of infection or disease of the urinary tract.

How other researchers are using Triglyceride Assay Kit ab65336
The Triglyceride assay kit has been used in publications in a variety of sample types, including:

  • - Human: serum1, plasma2, mammary epithelial and mammary cancer cell line lysate3, Huh7.5 hepatocyte-derived cell line lysate4, primary liver cell line lysates5, sebocyte cell culture lysates6
  • - Mouse: hepatocyte cell lysates7, liver extract8, serum9, plasma10, kidney extracts11, liver tissue and serum12, cardiac tissue extracts13
  • - Rat: liver tissue extract14, plasma15
  • - Drosophila16

References: 1-Huang Y et al. 2019, PMID: 30778327, 2-Wilson et al 2018; PMID: 29534545, 3-Yen MC et al. 2019, PMID: 30911270, 4-Kim D et al. 2018, PMID: 30127285, 5-Boteon Y et al. 2018, PMID: 30044872, 6- Jin S and Lee MY 2018, PMID: 30400322, 7-Zhang W et al. 2019, PMID: 30664220, 8-Brial F et al. 2019, PMID: 30842494, 9-Liu J et al. 2018, PMID: 30344653 and Patton A et al. 2018, PMID: 29666152, 10-Fernandes et al. 2018, PMID: 29320745 and Körholz JC et al 2018, PMID: 30362941 and Liang et al. 2018, PMID: 29659562, 11-Ding W et al. 2018, PMID: 29563333, 12-Cui XB et al. 2018, PMID: 29449334, 13-Rohm M et al. 2018<. PMID: 29610263, 14-Yu S et al. 2018, PMID: 29867579, 15-García-Ruiz et al. 2018, PMID: 29367725, 16-Wen CA and Ballard JWO 2019, PMID: 30805163

Related and recommended products
Triglyceride assay kit ab65336 is often used with Free Fatty Acid assay kit ab65341, and Cholesterol assay kit ab65390, to study lipid metabolism and its role in various metabolic diseases such as diabetes, obesity, liver diseases, and cardiovascular conditions.

Other notes
This product is manufactured by BioVision, an Abcam company and was previously called K622 Triglyceride Quantification Colorimetric/Fluorometric Kit. K622-100 is the same size as the 100 test size of ab65336.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

What's included?

{ "values": { "2000Test": { "sellingSize": "2000 Test", "publicAssetCode":"ab65336-2000Test", "assetComponentDetails": [ { "size":"20 x 300 µL", "name":"Triglyceride Standard", "number":"AB65336-CMP05" }, { "size":"20 x 0.2 mL", "name":"OxiRed™ Probe", "number":"AB65336-CMP04" }, { "size":"20 x 1 Vial", "name":"Enzyme Mix VI", "number":"AB65336-CMP03" }, { "size":"20 x 1 Vial", "name":"Cholesterol Esterase", "number":"AB65336-CMP01" }, { "size":"20 x 25 mL", "name":"Assay Buffer 5", "number":"AB65336-CMP02" } ] }, "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab65336-100Test", "assetComponentDetails": [ { "size":"1 x 300 µL", "name":"Triglyceride Standard", "number":"AB65336-CMP05", "productcode":"AB103967" }, { "size":"1 x 0.2 mL", "name":"OxiRed™ Probe", "number":"AB65336-CMP04", "productcode":"AB309437" }, { "size":"1 x 1 Vial", "name":"Enzyme Mix VI", "number":"AB65336-CMP03", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Cholesterol Esterase", "number":"AB65336-CMP01", "productcode":"AB198414" }, { "size":"1 x 25 mL", "name":"Assay Buffer 5", "number":"AB65336-CMP02", "productcode":"AB323940" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Triglycerides also known as triacylglycerols are a type of lipid molecule found mainly in adipose tissue and the bloodstream. They consist of three fatty acids bonded to a glycerol backbone leading to a total molecular mass that varies based on the fatty acid chain lengths. Triglycerides originate in different tissues like the liver and intestines. The enzyme lipase acts on triglycerides breaking them down into free fatty acids and glycerol which is essential for metabolic processes. Scientists often measure triglyceride levels in blood to assess lipid metabolism and related health conditions.
Biological function summary

Triglycerides serve as a major form of energy storage in the body. They are important substrates for energy production especially during fasting or prolonged physical activity when the body's glycogen stores are depleted. Triglycerides do not function independently but as part of lipoprotein complexes. These complexes transport lipids throughout the body in the bloodstream. Understanding the normal triglyceride range helps in assessing if levels are within a healthy limit indicating effective lipid metabolism. Average triglyceride levels may vary but maintaining a good triglyceride level is important for overall health.

Pathways

Triglycerides are involved in lipid metabolism and energy homeostasis. One important pathway includes the lipolysis pathway where triglycerides undergo breakdown via lipase into fatty acids and glycerol. This reaction is important for providing energy particularly involving proteins such as hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL). In another pathway triglycerides play a role in the synthesis and storage of fats influenced by proteins like peroxisome proliferator-activated receptors (PPARs) which regulate gene expression involved in fatty acid storage.

High triglyceride levels relate to cardiovascular disease and pancreatitis. Triglyceride-rich lipoproteins link to atherosclerosis making the regulation of triglycerides important for heart health. Chronic high levels may lead to acute pancreatitis by causing free fatty acid accumulation damaging pancreatic cells. Proteins such as apolipoprotein C-III affect triglyceride metabolism and may influence the risk of developing cardiovascular diseases. Effective management of triglyceride levels can help reduce these health risks.

Product protocols

This is a protocol summary; please use the downloadable protocol booklet for full instructions.

Triglyceride assay protocol

Reagent Prep
Freezing the 1mM Triglyceride Standard can cause it to separate. Heat the Triglyceride Standard in a boiling water bath to re-dissolve. Reconstitute lyophilized enzyme components. Other assay components are ready-to-use.

Sample Prep
Homogenize 1 x 107 cells / 100 mg of cells / tissue in 5% NP-40 solution. To solubilize triglycerides, heat to ~90°C in a water bath and then cool to room temperature twice. Spin out insoluble material with a microcentrifuge and then dilute samples in ddH2O.
Serum and other liquid samples: test directly without processing.

Notes:
- Serum typically contains 0.1 – 6 mM triglycerides.
- NP-40 works better than Triton X-100 or Tween-20 to keep lipids in solution and does not create assay background.
- Sodium azide content above 0.05% and phenol red (if the color of the sample well is affected) can interfere with the assay.

Triglyceride Assay Procedure
- Include spiked samples with a known amount of standard to adjust for any compounds that may interfere with the reaction.
- Use sample background controls to adjust for glycerol in samples which can generate high background signals.

1. Add samples, standards and controls to wells, and adjust volume with 50 µL with Assay Buffer 5. Dilute samples as required for the assay range.
2. Add Cholesterol Esterase to standard and sample wells. Mix and incubate with agitation for 20 minutes at RT to convert triglyceride to glycerol and fatty acid.
3. Prepare reaction mix containing Assay Buffer 5, OxiRed Probe and Enzyme Mix VI, and add to each well.
4. Mix and incubate at RT for 60 minutes, protected from light.
5. Measure output immediately on a microplate reader at OD 570 nm for colorimetric assay with a clear plate or Ex/Em= 535/587 nm for fluorometric assay with a black plate. The reaction is stable for at least 2 hours.

Calculations
Subtract the absorbance / fluorescence of the zero standard well from all readings, and of the sample background controls from sample readings. Plot the standard curve and use linear regression to calculate the concentration of triglyceride. Note: Triglyceride Standard molecular weight = 885.4 g/mol.
For spiked samples, subtract the sample reading from the spiked sample reading.

Publications (593)

Recent publications for all applications. Explore the full list and refine your search

Cellular and molecular life sciences : CMLS 82:270 PubMed40610622

2025

Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation.

Applications

Unspecified application

Species

Unspecified reactive species

Guangsi He,Wenzhu Shao,Weifei Wang,Lu Sun,Beibei Gao,Jie Wei

International journal of ophthalmology 18:986-995 PubMed40534810

2025

PPARα deficiency exacerbates retinal pathological changes and dysfunction in high-fat diet mice.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Wang,Jing-Jing Ding,Chao-Feng Yu,Deng-Cheng Xiao,Li-Ming Tao,Zheng-Xuan Jiang

Npj gut and liver 2: PubMed40519640

2025

Unlocking therapeutic potential of amlexanox in MASH with insights into bile acid metabolism and microbiome.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjing You,Jianfei Ji,Danwan Wen,Chen Wang,Xiaoli Sun,Peng Zhao

Journal of veterinary internal medicine 39:e70143 PubMed40476757

2025

Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses.

Applications

Unspecified application

Species

Unspecified reactive species

Miranda Dosi,Laura Scott,Holly Payne,Jacqueline Poldy,John Keen,Bruce McGorum,Alexandra Malbon,Ruth Morgan

Cell death & disease 16:425 PubMed40450000

2025

KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1.

Applications

Unspecified application

Species

Unspecified reactive species

Pengjie Yang,Benben Zhu,Hongwei Cui,Yongjun Yu,Qin Yu,Linghui Kong,Mengfei Sun,Yuan Liu,Bateer Han,Shuchen Chen

Cancer & metabolism 13:24 PubMed40410860

2025

Improved VPS4B O-GlcNAc modification triggers lipid droplets transferring from adipocytes to nasopharyngeal carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Haimeng Yin,Ying Shan,Qin Zhu,Ling Yuan,Feng Ju,Yu Shi,Yumo Han,Rui Wu,Tian Xia,Kaiwen Zhang,Yiwen You,Bo You

Experimental animals : PubMed40368825

2025

Comparison of the characteristics of non-alcoholic fatty liver disease in Lepr and Lepr mice.

Applications

Unspecified application

Species

Unspecified reactive species

Seungwoo Lee,Jae-Hong Min,Myoung Jun Kim,Somi Yun,Min Kyoung Seo,Jong Kwon Lee

Nature metabolism 7:1282-1298 PubMed40301583

2025

GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice.

Applications

Unspecified application

Species

Unspecified reactive species

Robert M Gutgesell,Ahmed Khalil,Arkadiusz Liskiewicz,Gandhari Maity-Kumar,Aaron Novikoff,Gerald Grandl,Daniela Liskiewicz,Callum Coupland,Ezgi Karaoglu,Seun Akindehin,Russell Castelino,Fabiola Curion,Xue Liu,Cristina Garcia-Caceres,Alberto Cebrian-Serrano,Jonathan D Douros,Patrick J Knerr,Brian Finan,Richard D DiMarchi,Kyle W Sloop,Ricardo J Samms,Fabian J Theis,Matthias H Tschöp,Timo D Müller

Scientific reports 15:15051 PubMed40301465

2025

ApoE4 requires lipidation enhancement to resolve cellular lipid and protein abnormalities following NPC1 inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Erika Di Biase,Kyle J Connolly,Ingrid Crumpton,Oliver Cooper,Penelope J Hallett,Ole Isacson

Biomedical reports 22:99 PubMed40297802

2025

Resveratrol ameliorates high‑fat diet‑induced insulin resistance via the DDIT4/mTOR pathway in skeletal muscle.

Applications

Unspecified application

Species

Unspecified reactive species

Xinyan Pan,Gangqiang Xue,Ming Zhao,Ziping Xiang,Dian Liu,Zesen Duan,Chao Wang
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com